🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
The purpose of this study is to evaluate whether HLA-mismatched donor G-CSF...
Status
Recruiting
Location
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Start Date
2025-06-20
Trial ID
NCT07078591
Treatments Being Tested
Using scintigraphic imaging including planar scintigraphy and SPECT, this s...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01
Trial ID
NCT01051622
Treatments Being Tested
The objective of this study is to evaluate the safety and immunologic effec...
Status
Terminated
Location
Providence Portland Medical Center
Start Date
2009-07
Trial ID
NCT00961376
Treatments Being Tested
The purpose of this study is to explore the combination of Elotuzumab in co...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2016-01
Trial ID
NCT02655458
Treatments Being Tested